Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × Sodium Chloride × Clear all

NCT00459654 2014-06-25

A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer

Phase 2 Completed

Neoplasm Metastasis, Prostatic Neoplasms